During the past decade, Fortis Escorts Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fortis Escorts Hospital" #1 collaborator was "Merck Ltd., India" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fortis Escorts Hospital" are "Colorectal Neoplasms" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Fortis Escorts Hospital" in a lesser frequency.

Most popular intervention types in "Fortis Escorts Hospital" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CRT Patients" (1 trials) and "Cetuximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fortis Escorts Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fortis Escorts Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fortis Escorts Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fortis Escorts Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".